Nitromint (Glyceryl Trinitrate Solution)

Glyceryl trinitrate is converted to nitric oxide in vascular smooth muscle. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels, which relaxes smooth muscle, dilates veins and arteries, lowers cardiac preload and afterload, and improves blood flow to the heart muscle.

The dose of Nitromint is individualized by the prescribing clinician based on the severity of angina, patient response, and any concomitant therapies. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.

Safety of glyceryl trinitrate in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

To order Nitromint, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitromint delivers glyceryl trinitrate as a sublingual solution, offering rapid onset of action similar to other nitroglycerin formulations but with the convenience of a liquid drop. Compared with oral tablets, the sublingual route bypasses first‑pass metabolism, providing quicker relief of angina symptoms.

Nitromint should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and heat sources to maintain stability and potency.

Nitromint is administered sublingually. The patient places the prescribed number of drops under the tongue and holds them there without swallowing for several seconds, allowing rapid absorption into the bloodstream for fast relief of chest pain.

The most serious risks include severe hypotension, which can lead to fainting or shock, methemoglobinemia—a rare blood disorder that reduces oxygen delivery, and allergic reactions such as rash or bronchospasm that may require immediate medical attention.

Nitromint is contraindicated in patients with known hypersensitivity to glyceryl trinitrate or other organic nitrates, those with severe anemia, and individuals who have taken phosphodiesterase‑5 inhibitors within the previous 24 hours due to the risk of dangerous blood pressure drops.